OASYS NOW

A Letter from Our Founder — Nima Salami When I was a child, my family fled Iran in search of safety. Each time we crossed a border, my mother — who lives with a chronic illness — lost her medical history. New doctors, new tests, new treatments, but the same uncertainty. The systems meant to heal her kept starting over. Years later, as I studied computer science and cybersecurity, I realized the problem wasn’t just medical — it was structural. Healthcare data is fragmented, locked away, and often too sensitive to move. As a result, the people who could benefit most from it — patients, physicians, and researchers — are left working with incomplete information. That realization shaped the mission of OASYS NOW. We are building technology that allows health data to be used safely, without being exposed — so that its value can serve everyone. For years, I’ve been researching privacy-by-design frameworks that make secure data sharing possible in healthcare. The goal is to enable the safe secondary use of health data: to let hospitals, scientists, and AI systems learn from it — while protecting every individual behind it. Imagine a future where AI can connect each patient’s unique medical history to the full landscape of available knowledge — approved medicines, clinical guidelines, trial opportunities, and the latest research. A kind of recommender system for health, built not to replace doctors, but to empower them — and to give patients access to the most suitable treatment options anywhere in the world. That’s what we’re working on. Not theoretical innovation, but practical trust — technology that hospitals can rely on, researchers can build upon, and patients can believe in. OASYS NOW is our effort to make healthcare both smarter and more humane. To prove that privacy and progress don’t have to compete. And to ensure that the systems we build today will still be serving patients long after we’re gone. — Nima Salami CEO & Co-Founder, OASYS NOW

Superconnectors take on OASYS NOW. No more using paper maps to get somewhere. Certainly not in healthcare! Health data should move freely and safe on the digital high ways.

💊 The uncomfortable truth about the medicine in your cabinet? It probably wasn’t designed for you... Historically, the vast majority of clinical trials have been run on a specific demographic: "Caucasian males". ❌ But the world is not made up of just one demographic. ✅ So, how much does that medicine actually "fit" you? At OASYS NOW, our mission is to change this narrative. We aren't just talking about personalized medicine as a luxury for the few; we are building the infrastructure to make it accessible to everyone globally. 🏗️ It starts with diversifying datasets. It starts with empowering patients to own their consent. It starts with a governance layer that bridges the gap between people and research. In this clip from my chat on The Builders Podcast with Proxify Developers, I break down exactly how we plan to democratize access to precision health. Watch the full clip below. 👇

From Nano-biology to CTO of OASYS NOW. Watch how Our CTO Sara Okhuijsen came to co-found OASYS NOW to make health data actionable and transparent for patients and their caregivers. www.youtube.com/watch?v=AZDA...

HOW ELaiGIBLE CT contributes to the SUSTAINABLE DEVELOPMENT GOALS ELaiGIBLE CT is a pioneering product developed by OASYS NOW that is fundamentally transforming the process of patient eligibility pre-screening for clinical trials. By leveraging advanced Explainable Artificial Intelligence (XAI), ELaiGIBLE addresses the critical bottleneck in medical research: the slow, costly, and often manual task of identifying suitable patients from complex, disparate health data. ELaiGIBLE contributes: Societal Impact and Inclusivity: Beyond its technological advancements, ELaiGIBLE is designed with a profound societal impact, focused on fairness, speed, and access to cutting-edge medicine. Increased Inclusivity and Fairness: By scanning every available data source—not just clean, structured fields—ELaiGIBLE ensures No Patients Are Missed. This capability is vital for including previously underrepresented groups in clinical trials, making the research process fairer and the resulting treatments relevant to a broader population. Accelerated Patient Access: By drastically increasing recruitment speed, the platform facilitates getting critical, new treatment options to patients and their families faster. This acceleration is crucial in time-sensitive fields, offering hope where traditional methods cause delays. Privacy-First Design: Recognizing the sensitivity of health data, the product is built on a Certified Privacy-First Infrastructure, adhering to rigorous standards like ISO 27001 and NEN 7510. It features one of the most extensive pseudonymisation pipelines on the market, ensuring that patient data is handled securely and responsibly—a commitment that earned it the Dutch Privacy Award.

Privacy-By-Design Is Non-Negotiable in Clinical AI Inside OASYS NOW’s commitment to building ethical, secure, and compliant infrastructure for the future of medicine. At OASYS NOW, trust isn’t a feature—it’s our foundation. From our first line of code to every real-world deployment, we’ve built our platform on the principles of privacy-by-design and compliance-by-default. As cybersecurity specialists with deep healthcare expertise, we don’t retrofit security—we embed it at the architecture level. Compliant with GDPR & EU AI Act Our infrastructure meets and exceeds Europe’s strictest regulatory frameworks, including the General Data Protection Regulation (GDPR) and the EU AI Act. All of our AI models and health data applications are designed for secure deployment, encrypted storage, and patient-level control, ensuring both legal compliance and ethical integrity. Award-Winning Cybersecurity Innovation We’ve been recognized across Europe for pushing the boundaries of privacy-enhancing technologies: 🥇 Netherlands Privacy Award 🛡 Europe’s AI Cybersecurity Award 🚀 Winner of SLUSH 100 – Europe’s top startup competition Our Cybersecurity DNA Nearly every member of our team is trained in cybersecurity, privacy engineering, or data law. That’s not an accident—it’s our culture. Whether we’re enabling confidential federated learning for genomics or pseudonymizing unstructured EHRs with our De-ID™ technology, we lead with security. We are among the only European companies capable of safely applying LLMs and Privacy-Preserving AI to clinical data at scale, inside hospitals, without compromising sensitive information. More Than Compliance—A Mission Our founders are a refugee AI engineer and a genomic privacy researcher. We’ve lived the consequences of broken health data systems. That’s why we build not just for technical compliance, but for ethical use, patient empowerment, and global inclusion.